Congress Asset Management »

Janux Therapeutics shares owned by Congress Asset Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Congress Asset Management from 13F filings

Historical chart of Congress Asset Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Congress Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Congress Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $791k 57k 13.80
2025-09-30 $1.4M 56k 24.44